We are live on ! Find out more
First Quadrant

First Quadrant Portfolio holdings

AUM $18M Turnover 89.22%
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.39%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.39%
2 Technology 15.39%
3 Healthcare 14.54%
4 Industrials 13.4%
5 Energy 11.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PETM
201
DELISTED
PetSmart
PETM
$4.8M 0.11%
80,300
– –
2013 Q2
4 quarters
TYL icon
202
Tyler Technologies
TYL
$16.1B
$4.79M 0.11%
52,500
– –
2013 Q2
4 quarters
FDX icon
203
FedEx
FDX
$71.2B
$4.78M 0.11%
31,600
– –
2013 Q2
4 quarters
WBA icon
204
DELISTED
Walgreens Boots Alliance
WBA
$4.74M 0.11%
63,900
+15,200
+31% +$1.06M
2013 Q2
4 quarters
OCR
205
DELISTED
Omnicare
OCR
$4.73M 0.11%
71,100
– –
2013 Q2
4 quarters
AXE
206
DELISTED
Anixter International
AXE
$4.71M 0.1%
47,101
– –
2013 Q2
4 quarters
AON icon
207
Aon
AON
$70.7B
$4.7M 0.1%
52,200
– –
2013 Q2
4 quarters
OA
208
DELISTED
Orbital ATK
OA
$4.66M 0.1%
34,787
-96,852
-74% -$13.4M
2013 Q2
4 quarters
OPLN icon
209
Openlane
OPLN
$4.11B
$4.62M 0.1%
383,354
+191,545
+100% +$2.21M
2014 Q1
1 quarter
NUS icon
210
Nu Skin
NUS
$185M
$4.62M 0.1%
62,443
-87,100
-58% -$6.86M
2013 Q2
4 quarters
LECO icon
211
Lincoln Electric
LECO
$13.6B
$4.54M 0.1%
64,900
-24,900
-28% -$1.69M
2013 Q4
2 quarters
RGC icon
212
DELISTED
Regal Entertainment Group
RGC
$4.5M 0.1%
213,300
– –
2013 Q2
4 quarters
CRL icon
213
Charles River Laboratories
CRL
$15.1B
$4.42M 0.1%
82,500
-73,900
-47% -$4.06M
2013 Q2
4 quarters
SAFM
214
DELISTED
Sanderson Farms
SAFM
$4.37M 0.1%
44,927
+36,227
+416% +$3.13M
2013 Q4
2 quarters
PEP icon
215
PepsiCo
PEP
$192B
$4.35M 0.1%
48,700
+1,000
+2% +$86.4K
2013 Q2
4 quarters
ANSS icon
216
DELISTED
Ansys
ANSS
$4.33M 0.1%
+57,100
New +$4.28M
2014 Q2
0 quarters
WRB icon
217
W.R. Berkley
WRB
$29.1B
$4.31M 0.1%
314,381
– –
2013 Q2
4 quarters
HST icon
218
Host Hotels & Resorts
HST
$16.5B
$4.28M 0.1%
194,300
+188,300
+3,138% +$4.05M
2013 Q2
4 quarters
CXT icon
219
Crane NXT
CXT
$2.94B
$4.26M 0.09%
164,967
– –
2013 Q2
4 quarters
TXN icon
220
Texas Instruments
TXN
$241B
$4.22M 0.09%
88,300
+75,100
+569% +$3.51M
2013 Q2
4 quarters
BHE icon
221
Benchmark Electronics
BHE
$1.99B
$4.22M 0.09%
165,477
+33,877
+26% +$797K
2013 Q2
4 quarters
SEIC icon
222
SEI Investments
SEIC
$11.9B
$4.2M 0.09%
128,000
– –
2014 Q1
1 quarter
PNC icon
223
PNC Financial Services
PNC
$84.7B
$4.17M 0.09%
46,790
– –
2013 Q2
4 quarters
SPXC icon
224
SPX
SPXC
$6.83B
$4.1M 0.09%
+150,501
New +$3.91M
2014 Q2
0 quarters
APA icon
225
APA
APA
$15.1B
$4.1M 0.09%
40,737
-400
-1% -$36.2K
2013 Q2
4 quarters

Similar funds

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited Bally Technologies in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.